This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Walgreens December Sales Increase 7.2 Percent

Stocks in this article: WAG

Walgreens (NYSE: WAG) (Nasdaq: WAG) had December sales of $7.20 billion, an increase of 7.2 percent from $6.72 billion for the same month in fiscal 2013.

Total front-end sales increased 4.0 percent compared with the same month in fiscal 2013, while comparable store front-end sales increased 2.5 percent. Customer traffic in comparable stores decreased 1.3 percent while basket size increased 3.8 percent.

Prescriptions filled at comparable stores increased by 5.3 percent in December and increased 2.4 percent on a calendar day-shift adjusted basis. December 2013 had one additional Tuesday and one fewer Saturday compared with December 2012. These calendar shifts positively impacted prescriptions filled at comparable stores by 2.9 percentage points.

Prescriptions filled at comparable stores were negatively impacted by 0.4 percentage point due to fewer flu shots in the month versus last year and were negatively impacted by 0.8 percentage point due to the lower incidence of flu in December 2013.

December pharmacy sales increased by 10.2 percent, while comparable store pharmacy sales increased 9.0 percent and increased by a calendar day-shift adjusted 6.1 percent. Calendar day shifts positively impacted pharmacy sales in comparable stores by 2.9 percentage points. Calendar day-shift adjusted comparable store pharmacy sales were negatively impacted by 1.2 percentage points due to generic drug introductions in the last 12 months, and were negatively impacted by 0.2 percentage point due to fewer flu shots in December versus last year. The lower incidence of flu negatively impacted pharmacy sales by 0.4 percentage point. Pharmacy sales accounted for 58.3 percent of total sales for the month.

Flu shots administered at pharmacies and clinics season to date were more than 6.7 million versus nearly 5.5 million last year.

Sales in comparable stores increased by 6.1 percent in December. Calendar day shifts positively impacted total comparable sales by 1.7 percentage points, while generic drug introductions in the last 12 months negatively impacted total comparable sales by 0.7 percentage point.

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs